» Articles » PMID: 22700684

Does Surgical Debulking for Advanced Stages of Thymoma Improve Survival?

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

A best evidence topic in cardiothoracic surgery was written according to a structured protocol. The question addressed was 'Does surgical debulking for advanced stages of thymoma improve survival?' Altogether, only 17 papers were found using the reported search, of which only 10 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated; these studies have mainly reported the survival and recurrence rates after total vs subtotal resection of thymic tumours in patients receiving or not receiving adjuvant chemoradiotherapy. These studies confirmed that complete resection is the best prognostic factor in thymomas. With regard to subtotal tumour resection/debulking, we did not find any randomized controlled trials. The evidence on this topic is scarce and these 10 reported were retrospective reviews of the operative, histology and survival data of patients with thymoma who had subtotal vs partial resection for advanced stages of thymoma. Although debulking surgery for thymoma had positively affected survival, in six studies, the difference failed to reach statistical significance. Three of the studies, on the other hand, showed a higher survival rate in thymomas in which maximum debulking was performed and the treatment was followed by high-dose irradiation. None of these studies showed any benefit in debulking surgery for thymic carcinoma. Besides histology and tumour cell-type, other factors influencing survival included the tumour stage and the presence of symptoms such as myasthenia gravis as a warning sign at an early stage. Current evidence in the literature on the survival after debulking surgery for thymoma is contradictory, and most of the studies do not show any survival benefit after debulking for thymoma. However, debulking surgery minimizes the tumour size and area for irradiation postoperatively, hence it can result in less damage to the adjacent tissue during radiotherapy and may be considered for patients in advanced stages of thymoma in whom extensive radiotherapy will be required. In these cases, however, the risks of surgery followed by radiotherapy or radiotherapy alone should carefully be assessed prior to the initiation of treatment.

Citing Articles

Effectiveness of Adjuvant Chemo- and Radiotherapy in Thymic Carcinoma Stage II: A Systematic Review and Meta-Analysis.

Nazzal A, Yayan J, Biancosino C, Tabatabaei S, Hekmat K Cancer Control. 2025; 31:10732748241292781.

PMID: 39865594 PMC: 11503756. DOI: 10.1177/10732748241292781.


Surgical management of thymic tumors: a narrative review with focus on robotic-assisted surgery.

Deckarm R, Flury D, Deckarm S, Ott S, Kocher G Mediastinum. 2025; 8():48.

PMID: 39781201 PMC: 11707441. DOI: 10.21037/med-24-17.


Surgical treatment of thymic epithelial tumors: a narrative review.

Agrafiotis A, Berzenji L, Koyen S, Vermeulen D, Winthagen R, Hendriks J Mediastinum. 2024; 8:32.

PMID: 38881810 PMC: 11176987. DOI: 10.21037/med-23-44.


Intuitive evaluation of contemporary management strategies in thymoma - the largest Indian experience.

Lal Chowdhary R, Chufal K, Ismail M, Ahmad I, Jwala M, Pahuja A Rep Pract Oncol Radiother. 2023; 28(4):454-462.

PMID: 37795230 PMC: 10547419. DOI: 10.5603/RPOR.a2023.0050.


Thymoma and Thymic Carcinoma: Surgical Resection and Multidisciplinary Treatment.

Zhang Y, Lin D, Aramini B, Yang F, Chen X, Wang X Cancers (Basel). 2023; 15(7).

PMID: 37046614 PMC: 10093507. DOI: 10.3390/cancers15071953.


References
1.
Akoum R, Brihi E, Chammas S, Abigerges D . Results of radiation therapy for thymoma based on a review of 27 patients. Mol Immunol. 2003; 39(17-18):1115-9. DOI: 10.1016/s0161-5890(03)00081-6. View

2.
Liu H, Chen Y, Tzen C, Huang C, Chang C, Huang W . Debulking surgery for advanced thymoma. Eur J Surg Oncol. 2006; 32(9):1000-5. DOI: 10.1016/j.ejso.2006.03.049. View

3.
Lin J, Wei-Shu W, Yen C, Liu J, Chen P, Chiou T . Stage IV thymic carcinoma: a study of 20 patients. Am J Med Sci. 2005; 330(4):172-5. DOI: 10.1097/00000441-200510000-00004. View

4.
Dunning J, Prendergast B, Mackway-Jones K . Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact Cardiovasc Thorac Surg. 2007; 2(4):405-9. DOI: 10.1016/S1569-9293(03)00191-9. View

5.
Falkson C, Bezjak A, Darling G, Gregg R, Malthaner R, Maziak D . The management of thymoma: a systematic review and practice guideline. J Thorac Oncol. 2009; 4(7):911-9. DOI: 10.1097/jto.0b013e3181a4b8e0. View